John Koconis - Aug 20, 2023 Form 4 Insider Report for Timber Pharmaceuticals, Inc. (TMBR)

Role: CEO & Chairman
Signature: /s/ Joseph Lucchese, Power of Attorney
Stock symbol: TMBR
Transactions as of: Aug 20, 2023
Transactions value $: $0
Form type: 4
Date filed: 8/22/2023, 07:46 PM
Previous filing: Apr 18, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMBR	Common Stock, par value $0.001 per share	Award	$0	+70.4K	+17596.25%	$0.00	70.8K	Aug 20, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On August 20, 2023, the Reporting Person was granted 70,385 restricted stock units ("RSUs"), which will be settled in shares of common stock, par value $0.001. 25% of the RSUs vest on August 20, 2024, and the remaining RSUs vest in 36 equal monthly installments beginning on September 20, 2024, as long as the Reporting Person remains in continuous service with the Issuer through each vesting date; provided, however, that the RSUs will vest in full in the event that a "Change in Control" (as defined in the Issuer's 2020 Omnibus Incentive Plan) occurs while the Reporting Person remains in continuous service with the Issuer.

Content

On August 20, 2023, the Reporting Person was granted 70,385 restricted stock units ("RSUs"), which will be settled in shares of common stock, par value $0.001. 25% of the RSUs vest on August 20, 2024, and the remaining RSUs vest in 36 equal monthly installments beginning on September 20, 2024, as long as the Reporting Person remains in continuous service with the Issuer through each vesting date; provided, however, that the RSUs will vest in full in the event that a "Change in Control" (as defined in the Issuer's 2020 Omnibus Incentive Plan) occurs while the Reporting Person remains in continuous service with the Issuer.